MediMedia Managed Markets
Managed Care magazine
P&T Community, The Online Resource for P&T Decision Makers
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager

Statement of Purpose
Guidelines for Authors
Editorial Board

Recent Issues

February 2003


Cover Story

Meta-analysis: Effect of ACE-Inhibitors on Outcomes in Patients with Renal Insufficiency

The authors explain the benefits of ACE-inhibitors in controlling the progression of renal disease.
Tomoko Terajima, MS Pharm, Shin-ichi Yamagata, MS Pharm, Nobunori Satoh, PhD, and Shiro Ueda, MD

Physician Perspective

The Struggle to Heal an Angry Patient

A family practitioner discovers some of the lessons to be learned from treating a terminally ill patient.
Thomas Marzili, MD

Pharmaceutical-Approval Update

Pharmaceutical-Approval Update

The author reviews ezetimibe for lowering blood lipid levels, atomoxetine for attention-deficit hyperactivity disorder, and injectable teriparatide for osteoporosis.
Marvin M. Goldenberg, PhD

Letter to the Editor

Direct-to-Consumer Marketing Generates Calls: Is the Pharmaceutical Industry Prepared?

Drug companies can satisfy their customers by responding to their increasing demands for information.
Paul Spiegelman


Imiquimod Cream: A New Multipurpose Topical Therapy for Dermatology

The authors discuss a new topical therapeutic agent for the treatment of genital warts and other skin conditions.
David J. Najarian, BS, and Joseph C. English III, MD



California’s Integrated Healthcare Association

Editor-in-Chief Dr. David Nash reports on California’s Integrated Healthcare Association.
David B. Nash, MD, MBA

Medication Errors

Computer-Generated MAR Format: A Source of Errors?

Matthew Grissinger describes the potential pitfalls of pharmacy computer-generated medication administration records.
Matthew Grissinger

Drug News

New Drugs/Drug News

The latest information about approvals, indication changes, industry updates, and news from the FDA.

Prescription Washington

FDA’s Proposal on Generics Pleases No One

Stephen Barlas discusses the FDA’s latest proposal on generic drugs.
Stephen Barlas

Drug Forecast

Eplerenone: A Novel Selective Aldosterone Blocker for Hypertension

Drs. Kleyman and Sisca review eplerenone for the treatment of hypertension.
Jennie Kleyman, PharmD, and Thomas S. Sisca, PharmD

P&T Snapshot

Treating Hypertension: Beta Blockers Surpass ACE-Inhibitors

Both ACE-inhibitors and beta blockers are commonly prescribed for patients with hypertension, but the numbers are changing.